Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 12, 2023

BUY
$6.35 - $8.16 $12,700 - $16,320
2,000 New
2,000 $14,000
Q3 2021

Oct 06, 2021

SELL
$5.52 - $15.83 $73,140 - $209,747
-13,250 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$9.02 - $12.72 $2,435 - $3,434
270 Added 2.08%
13,250 $166,000
Q1 2021

Apr 30, 2021

SELL
$8.48 - $11.28 $2,187 - $2,910
-258 Reduced 1.95%
12,980 $133,000
Q4 2020

Jan 25, 2021

SELL
$5.32 - $10.17 $2,660 - $5,085
-500 Reduced 3.64%
13,238 $121,000
Q1 2020

May 12, 2020

SELL
$3.17 - $7.54 $31,700 - $75,400
-10,000 Reduced 42.13%
13,738 $52,000
Q4 2019

Jan 17, 2020

SELL
$4.67 - $7.58 $4,670 - $7,580
-1,000 Reduced 4.04%
23,738 $172,000
Q3 2019

Nov 07, 2019

BUY
$3.99 - $5.71 $98,704 - $141,253
24,738 New
24,738 $123,000
Q1 2019

May 15, 2019

SELL
$1.84 - $3.74 $45,517 - $92,520
-24,738 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$1.15 - $6.45 $11,155 - $62,565
9,700 Added 64.5%
24,738 $44,000
Q3 2018

Oct 25, 2018

BUY
$3.22 - $6.33 $48,422 - $95,190
15,038 New
15,038 $0
Q2 2018

Aug 07, 2018

SELL
$5.39 - $8.96 $4,915 - $8,171
-912 Closed
0 $0
Q1 2018

Jun 03, 2019

BUY
$6.69 - $17.96 $6,101 - $16,379
912 New
912 $12,000
Q1 2018

May 09, 2018

SELL
$6.69 - $17.96 $6,101 - $16,379
-912 Closed
0 $0
Q4 2017

Jan 24, 2018

SELL
$10.87 - $13.9 $2,717 - $3,475
-250 Reduced 21.51%
912 $0
Q3 2017

Oct 30, 2017

BUY
$11.86 - $17.34 $8,895 - $13,005
750 Added 182.04%
1,162 $14,000
Q2 2017

Jun 03, 2019

SELL
N/A
-800 Reduced 66.01%
412 $6,000
Q1 2017

Jun 03, 2019

SELL
N/A
-1,000 Reduced 45.21%
1,212 $12,000
Q4 2016

Jun 03, 2019

SELL
N/A
-588 Reduced 21.0%
2,212 $20,000
Q2 2016

Jun 03, 2019

BUY
N/A
2,800
2,800 $22,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.